(CMP) Compass Minerals - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US20451N1019
Stock:
Total Rating 59
Risk 76
Buy Signal 0.30
| Risk 5d forecast | |
|---|---|
| Volatility | 65.2% |
| Relative Tail Risk | -7.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.55 |
| Alpha | 92.61 |
| Character TTM | |
|---|---|
| Beta | 0.955 |
| Beta Downside | 0.459 |
| Drawdowns 3y | |
|---|---|
| Max DD | 80.48% |
| CAGR/Max DD | -0.17 |
EPS (Earnings per Share)
Revenue
Description: CMP Compass Minerals
Compass Minerals International, Inc. provides essential minerals in the United States, Canada, the United Kingdom, and internationally. It operates through two segments, Salt and Plant Nutrition. The Salt segment produces, markets, and sells sodium chloride and magnesium chloride, including rock salt, mechanically and solar evaporated salt, and brine and flake magnesium chloride products; and purchases and sells potassium chloride and calcium chloride to sell as finished products or to blend with sodium chloride to produce specialty products. This segment provides products for use as a deicer for roadways, consumer, and professional use; as an ingredient in chemical production; for water treatment, human, and animal nutrition; and for various other consumer and industrial uses, as well as records management services. The Plant Nutrition segment produces sulfate of potash specialty fertilizers in various grades that are used in broadcast spreaders, direct application, and liquid fertilizer solutions under the Protassium+ brand name; turf products used by the turf and ornamental markets, as well as for blends used on golf course greens; and organic products. This segment provides its products to distributors and retailers of crop inputs, as well as growers. The company was formerly known as Salt Holdings Corporation and changed its name to Compass Minerals International, Inc. in December 2003. Compass Minerals International, Inc. was founded in 1844 and is headquartered in Overland Park, Kansas.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -37.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 7.60 > 1.0 |
| NWC/Revenue: 29.15% < 20% (prev 37.20%; Δ -8.05% < -1%) |
| CFO/TA 0.11 > 3% & CFO 164.8m > Net Income -37.6m |
| Net Debt (850.2m) to EBITDA (149.1m): 5.70 < 3 |
| Current Ratio: 2.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (42.3m) vs 12m ago 1.99% < -2% |
| Gross Margin: 16.48% > 18% (prev 0.15%; Δ 1633 % > 0.5%) |
| Asset Turnover: 82.08% > 50% (prev 62.93%; Δ 19.15% > 0%) |
| Interest Coverage Ratio: 0.66 > 6 (EBITDA TTM 149.1m / Interest Expense TTM 69.7m) |
Altman Z'' 1.60
| A: 0.25 (Total Current Assets 632.2m - Total Current Liabilities 243.7m) / Total Assets 1.53b |
| B: -0.04 (Retained Earnings -59.0m / Total Assets 1.53b) |
| C: 0.03 (EBIT TTM 46.3m / Avg Total Assets 1.62b) |
| D: -0.13 (Book Value of Equity -159.8m / Total Liabilities 1.27b) |
| Altman-Z'' Score: 1.60 = BB |
Beneish M -3.45
| DSRI: 0.86 (Receivables 278.6m/261.7m, Revenue 1.33b/1.08b) |
| GMI: 0.89 (GM 16.48% / 14.61%) |
| AQI: 0.59 (AQ_t 0.08 / AQ_t-1 0.14) |
| SGI: 1.23 (Revenue 1.33b / 1.08b) |
| TATA: -0.13 (NI -37.6m - CFO 164.8m) / TA 1.53b) |
| Beneish M-Score: -3.45 (Cap -4..+1) = AA |
What is the price of CMP shares?
As of February 26, 2026, the stock is trading at USD 24.86 with a total of 505,415 shares traded.
Over the past week, the price has changed by +5.21%, over one month by -0.76%, over three months by +34.67% and over the past year by +111.39%.
Over the past week, the price has changed by +5.21%, over one month by -0.76%, over three months by +34.67% and over the past year by +111.39%.
Is CMP a buy, sell or hold?
Compass Minerals has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy CMP.
- StrongBuy: 1
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CMP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23 | -7.5% |
| Analysts Target Price | 23 | -7.5% |
CMP Fundamental Data Overview February 22, 2026
P/E Forward = 14.2045
P/S = 0.6433
P/B = 3.8553
P/EG = 0.1337
Revenue TTM = 1.33b USD
EBIT TTM = 46.3m USD
EBITDA TTM = 149.1m USD
Long Term Debt = 883.6m USD (from longTermDebt, last quarter)
Short Term Debt = 6.90m USD (from shortTermDebt, last quarter)
Debt = 896.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 850.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.82b USD (974.2m + Debt 896.9m - CCE 46.7m)
Interest Coverage Ratio = 0.66 (Ebit TTM 46.3m / Interest Expense TTM 69.7m)
EV/FCF = 19.39x (Enterprise Value 1.82b / FCF TTM 94.1m)
FCF Yield = 5.16% (FCF TTM 94.1m / Enterprise Value 1.82b)
FCF Margin = 7.06% (FCF TTM 94.1m / Revenue TTM 1.33b)
Net Margin = -2.82% (Net Income TTM -37.6m / Revenue TTM 1.33b)
Gross Margin = 16.48% ((Revenue TTM 1.33b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 15.96% (prev 16.88%)
Tobins Q-Ratio = 1.19 (Enterprise Value 1.82b / Total Assets 1.53b)
Interest Expense / Debt = 2.02% (Interest Expense 18.1m / Debt 896.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 36.6m (EBIT 46.3m * (1 - 21.00%))
Current Ratio = 2.59 (Total Current Assets 632.2m / Total Current Liabilities 243.7m)
Debt / Equity = 3.44 (Debt 896.9m / totalStockholderEquity, last quarter 260.5m)
Debt / EBITDA = 5.70 (Net Debt 850.2m / EBITDA 149.1m)
Debt / FCF = 9.04 (Net Debt 850.2m / FCF TTM 94.1m)
Total Stockholder Equity = 245.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.32% (Net Income -37.6m / Total Assets 1.53b)
RoE = -15.33% (Net Income TTM -37.6m / Total Stockholder Equity 245.2m)
RoCE = 4.10% (EBIT 46.3m / Capital Employed (Equity 245.2m + L.T.Debt 883.6m))
RoIC = 3.38% (NOPAT 36.6m / Invested Capital 1.08b)
WACC = 5.67% (E(974.2m)/V(1.87b) * Re(9.43%) + D(896.9m)/V(1.87b) * Rd(2.02%) * (1-Tc(0.21)))
Discount Rate = 9.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 1.21%
[DCF] Terminal Value 80.82% ; FCFF base≈94.1m ; Y1≈61.8m ; Y5≈28.2m
[DCF] Fair Price = 1.14 (EV 898.0m - Net Debt 850.2m = Equity 47.8m / Shares 41.9m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -8.69 | EPS CAGR: 7.31% | SUE: 0.39 | # QB: 0
Revenue Correlation: -4.80 | Revenue CAGR: -3.26% | SUE: 1.92 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.59 | Chg7d=-0.059 | Chg30d=-0.046 | Revisions Net=+2 | Analysts=3
EPS current Year (2026-09-30): EPS=0.71 | Chg7d=-0.037 | Chg30d=+0.016 | Revisions Net=+1 | Growth EPS=+248.9% | Growth Revenue=-1.2%
EPS next Year (2027-09-30): EPS=0.99 | Chg7d=-0.018 | Chg30d=-0.005 | Revisions Net=+1 | Growth EPS=+38.4% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
P/S = 0.6433
P/B = 3.8553
P/EG = 0.1337
Revenue TTM = 1.33b USD
EBIT TTM = 46.3m USD
EBITDA TTM = 149.1m USD
Long Term Debt = 883.6m USD (from longTermDebt, last quarter)
Short Term Debt = 6.90m USD (from shortTermDebt, last quarter)
Debt = 896.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 850.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.82b USD (974.2m + Debt 896.9m - CCE 46.7m)
Interest Coverage Ratio = 0.66 (Ebit TTM 46.3m / Interest Expense TTM 69.7m)
EV/FCF = 19.39x (Enterprise Value 1.82b / FCF TTM 94.1m)
FCF Yield = 5.16% (FCF TTM 94.1m / Enterprise Value 1.82b)
FCF Margin = 7.06% (FCF TTM 94.1m / Revenue TTM 1.33b)
Net Margin = -2.82% (Net Income TTM -37.6m / Revenue TTM 1.33b)
Gross Margin = 16.48% ((Revenue TTM 1.33b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 15.96% (prev 16.88%)
Tobins Q-Ratio = 1.19 (Enterprise Value 1.82b / Total Assets 1.53b)
Interest Expense / Debt = 2.02% (Interest Expense 18.1m / Debt 896.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 36.6m (EBIT 46.3m * (1 - 21.00%))
Current Ratio = 2.59 (Total Current Assets 632.2m / Total Current Liabilities 243.7m)
Debt / Equity = 3.44 (Debt 896.9m / totalStockholderEquity, last quarter 260.5m)
Debt / EBITDA = 5.70 (Net Debt 850.2m / EBITDA 149.1m)
Debt / FCF = 9.04 (Net Debt 850.2m / FCF TTM 94.1m)
Total Stockholder Equity = 245.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -2.32% (Net Income -37.6m / Total Assets 1.53b)
RoE = -15.33% (Net Income TTM -37.6m / Total Stockholder Equity 245.2m)
RoCE = 4.10% (EBIT 46.3m / Capital Employed (Equity 245.2m + L.T.Debt 883.6m))
RoIC = 3.38% (NOPAT 36.6m / Invested Capital 1.08b)
WACC = 5.67% (E(974.2m)/V(1.87b) * Re(9.43%) + D(896.9m)/V(1.87b) * Rd(2.02%) * (1-Tc(0.21)))
Discount Rate = 9.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 1.21%
[DCF] Terminal Value 80.82% ; FCFF base≈94.1m ; Y1≈61.8m ; Y5≈28.2m
[DCF] Fair Price = 1.14 (EV 898.0m - Net Debt 850.2m = Equity 47.8m / Shares 41.9m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -8.69 | EPS CAGR: 7.31% | SUE: 0.39 | # QB: 0
Revenue Correlation: -4.80 | Revenue CAGR: -3.26% | SUE: 1.92 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.59 | Chg7d=-0.059 | Chg30d=-0.046 | Revisions Net=+2 | Analysts=3
EPS current Year (2026-09-30): EPS=0.71 | Chg7d=-0.037 | Chg30d=+0.016 | Revisions Net=+1 | Growth EPS=+248.9% | Growth Revenue=-1.2%
EPS next Year (2027-09-30): EPS=0.99 | Chg7d=-0.018 | Chg30d=-0.005 | Revisions Net=+1 | Growth EPS=+38.4% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)